Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225522 · ClinicalTrials.gov registry record · NA
Genomic Sequencing in Acutely Ill Neonates
A NA study of Genetic Disease and Diseases/Diagnoses, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02225522 is a NA study of Genetic Disease and Diseases/Diagnoses that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 65 participants, below the 2,559-participant average among 30 other Genetic Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02225522, a NA study of Genetic Disease and Diseases/Diagnoses, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of rapid next generation sequencing (NGS, such as whole genome sequencing1) with current practice to provide diagnostic or prognostic information or treatment guidance in acutely ill neonates and infants, particularly with respect to clinical care, cost and outcomes.
Conditions Studied
Interventions
- OTHER Rapid whole genome sequencing (StatSeq)
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02225522
The ClinicalTrials.gov registry entry for NCT02225522 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,559-participant average among 30 other Genetic Disease trials with a reported enrollment target (97% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Rapid whole genome sequencing (StatSeq) is the first listed.
NCT02225522 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02225522 about?
NCT02225522 is a clinical study titled "Genomic Sequencing in Acutely Ill Neonates". The purpose of this study is to compare the effectiveness of rapid next generation sequencing (NGS, such as whole genome sequencing1) with current practice to provide diagnostic or prognostic information or treatment guidance in acutely ill neonates and infants, particularly with respect to clinical...
What is the current status of trial NCT02225522?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2014-10. Estimated completion is 2016-09.
What conditions does trial NCT02225522 study?
This clinical trial studies the following conditions: Genetic Disease, Diseases/Diagnoses.
What interventions are being tested in trial NCT02225522?
The interventions under investigation include: Rapid whole genome sequencing (StatSeq) (OTHER).
Who is sponsoring clinical trial NCT02225522?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02225522 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Large Language Models To Improve the Quality of Care of Cardiology Patients
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.